Alterity Therapeutics (ATHE) Other Working Capital Changes (2009 - 2020)
Alterity Therapeutics (ATHE) recorded quarterly Other Working Capital Changes of $35152.2 in Q2 2020, up 115.98% quarter-over-quarter from -$220011.4 in Q4 2019, and up 113.74% on a YoY basis from $16446.0 in Q3 2019.
Alterity Therapeutics (ATHE) Other Working Capital Changes (2009 - 2020) Analysis & Trends
Alterity Therapeutics' Other Working Capital Changes history runs 9 years deep, the most recent figure standing at $35152.2 for Q2 2020.
- In Q2 2020, Other Working Capital Changes rose 113.74% year-over-year to $35152.2; the TTM figure through Jun 2020 stood at -$551073.5 (down 72.53% YoY), while the FY2025 annual figure was $692540.8, up 315.38% from the prior year.
- Other Working Capital Changes was $35152.2 for Q2 2020 at Alterity Therapeutics, up from -$220011.4 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $46670.6 in Q4 2017 to a low of -$255773.2 in Q2 2019.
- Historically, Other Working Capital Changes has averaged -$77106.7 across 5 years, with a median of -$86350.9 in 2016.
- The sharpest annual moves came in 2017 and 2019: Other Working Capital Changes jumped 146.53% in 2017, then tumbled 178033.96% in 2019.
- A 5-year view of Other Working Capital Changes shows it stood at -$100293.2 in 2016, then surged by 146.53% to $46670.6 in 2017, then sank by 336.64% to -$110441.0 in 2018, then plunged by 99.21% to -$220011.4 in 2019, then soared by 115.98% to $35152.2 in 2020.
- The last three Other Working Capital Changes figures came in at $35152.2 (Q2 2020), -$220011.4 (Q4 2019), and -$255773.2 (Q2 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 35,152.17 |
| Jun 30, 2020 | 35,152.17 |
| Dec 31, 2019 | -220,011.42 |
| Dec 31, 2019 | -220,011.42 |
| Jun 30, 2019 | -255,773.25 |
| Jun 30, 2019 | -255,773.25 |
| Dec 31, 2018 | -110,441.04 |
| Dec 31, 2018 | -110,441.04 |
| Jun 30, 2018 | 143.75 |
| Jun 30, 2018 | 143.75 |
| Dec 31, 2017 | 46,670.64 |
| Dec 31, 2017 | 46,670.64 |
| Jun 30, 2017 | -3,056.67 |
| Jun 30, 2017 | -3,056.67 |
| Dec 31, 2016 | -100,293.18 |
| Dec 31, 2016 | -100,293.18 |
| Jun 30, 2016 | -86,350.91 |
| Jun 30, 2016 | -86,350.91 |
| Dec 31, 2015 | -33,251.12 |
| Dec 31, 2015 | -33,251.12 |